Poland· PL-100016831

Dafnegin

A ciclopirox product containing ciclopirox olaminum, registered in Poland by Polichem S.A.. The same ATC class is registered in 2 of our 19 countries.

ATC G01AX12

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedDafneginATCG01AX12REGISTER NO.PL-100016831PACKS LISTED1CHECKEDSeptember 27, 2026

Where it is registered

Ciclopirox is registered in 2 of 19 countries.

Countries holding a registration under ATC G01AX12 (ciclopirox), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 2 of them publish a price we can compare per daily dose

Ciclopirox · ATC G01AX12

2 / 19 countries

  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of ciclopirox costs, country by country.

Normalised to the WHO defined daily dose (50 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Ciclopirox · price per daily dose (50 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$1.57
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

URPL (Poland)
Active substance
Ciclopirox olaminum
Manufacturer
Polichem S.A.
Country
Poland (PL)
ATC code
G01AX12
ATC class
Ciclopirox
Defined daily dose
50 mg, V
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 1

  • gtin
    05909990154111

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

118 interactions on record for ciclopirox.

Graded by severity as the source publishes them — 118 info. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Ciclopirox · interactions on record

118 records

Interaction register. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/59b94576-706c-45f1-88c3-99e102be9281
GET /v1/drugs/59b94576-706c-45f1-88c3-99e102be9281?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Krem dopochwowy",
  "source": "urpl",
  "strength": "10 mg/g",
  "packaging": "05909990154111 ¦ Rp ¦ 2850\n1 tuba 78 g ¦ 14 aplikatorów",
  "substance": "Ciclopirox olaminum 1 g",
  "common_name": "Ciclopirox olaminum",
  "pl_product_id": "100016831",
  "pozwolenie_nr": "01541",
  "auth_procedure": "NAR",
  "authorisation_validity": "Bezterminowe"
}

See everything about ciclopirox.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.